深圳 重大发布！

Core Viewpoint - Shenzhen Municipal Government has issued the "Implementation Measures for Further Attracting and Utilizing Foreign Investment," which includes 22 measures aimed at enhancing foreign investment, particularly in the biopharmaceutical sector [1][2]. Group 1: Support for Biopharmaceutical Industry - The measures aim to create an international research and innovation hub, encouraging foreign investment in the biopharmaceutical field [1]. - Foreign-invested enterprises are encouraged to conduct clinical trials for overseas-listed cell and gene therapy drugs in Shenzhen, accelerating the establishment of an international clinical trial center in the Guangdong-Hong Kong-Macao Greater Bay Area [1]. - The plan includes facilitating the approval of urgently needed drugs and medical devices from Hong Kong and Macau for use in designated medical institutions in Shenzhen [1]. Group 2: Expanding Foreign Investment Channels - Foreign investment companies setting up in Shenzhen can enjoy the same treatment as domestic enterprises under relevant regulations [2]. - The measures promote foreign investment through mergers, cross-border RMB contributions, equity contributions, and reinvestment of distributed profits [2]. - The implementation of Qualified Foreign Limited Partner (QFLP) investment trials will be deepened, with an emphasis on promoting the total management system of QFLP [2]. Group 3: Optimizing Business Environment - The measures propose to enhance the business environment, improve investment operation convenience, and increase financial support [2]. - From 2025 to 2027, foreign multinational companies' regional headquarters and global headquarters that meet certain criteria will receive a one-time reward of up to 8 million yuan if they achieve a minimum of 10 million USD in actual foreign investment [2]. - Foreign R&D centers recognized by Shenzhen's foreign investment authorities will receive a one-time reward of up to 1 million yuan, with additional incentives for multinational global R&D centers [2]. Group 4: Data Cross-Border Flow Management - The measures explore a safe management mechanism for the cross-border flow of data, supporting foreign-invested enterprises in data movement with their headquarters [3]. - A pilot program for the safe management of cross-border data transmission will be conducted under the national and industry frameworks [3]. - The establishment of data cross-border flow service platforms and verification platforms in cooperation zones will provide compliance services for data movement [3]. Group 5: Recent Achievements - Since the beginning of the 14th Five-Year Plan, Shenzhen has established 41,000 new foreign-invested enterprises, accounting for 15.7% of the national total, with actual foreign investment nearing 300 billion yuan [3]. - Analysts suggest that Shenzhen is evolving from merely being a market entry point for multinational companies to participating more actively in advanced technology and product development [3].